Table 3 |
||||
|
Antimalarial treatments for children with uncomplicated malaria presenting to health facilities with artemether-lumefantrine in stock – change of practice between 2004 and 2006 surveys in four districts in Zambia |
||||
| 2004 |
5–9 kg (N = 254) |
≥ 10 kg (N = 192) |
||
|
|
||||
| No (%) |
95% CI* |
No (%) |
95% CI* |
|
|
|
||||
| Artemether-lumefantrine |
6 (2.4) |
0, 5.7 |
42 (21.9) |
12.4, 31.3 |
| Sulphadoxine-pyrimethamine |
183 (72.1) |
61.0, 83.1 |
103 (53.7) |
39.7, 67.6 |
| Quinine |
9 (3.5) |
0.3, 6.8 |
6 (3.1) |
0.4, 5.9 |
| No antimalarial prescribed |
56 (22.1) |
11.6, 32.5 |
41 (21.4) |
12.7, 30.0 |
|
|
||||
| 2006 |
5–9 kg (N = 351) |
≥ 10 kg (N = 374) |
||
|
|
||||
| No (%) |
95% CI* |
No (%) |
95% CI* |
|
|
|
||||
| Artemether-lumefantrine |
144 (41.0) |
31.5, 50.5 |
219 (58.6) |
50.2, 66.9 |
| Sulphadoxine-pyrimethamine |
77 (21.9) |
15.4, 28.5 |
51 (13.6) |
7.1, 20.2 |
| Quinine |
8 (2.3) |
0.1, 4.5 |
14 (3.7) |
0, 7.9 |
| No antimalarial prescribed |
122 (34.8) |
27.2, 42.3 |
90 (24.1) |
17.4, 30.7 |
|
|
||||
|
* Confidence intervals adjusted for cluster sampling |
||||
|
Zurovac et al. Malaria Journal 2007 6:31 doi:10.1186/1475-2875-6-31 |
||||
